These glutamine‐dependent cancer cells rely heavily on glutamine and exhibit sensitivity to either glutamine deprivation or the inhibition of glutaminase.[14] Given the essential role of glutamine metabolism in cancer development and growth,[15] numerous glutaminolysis inhibitors have been developed and are being tested in clinical trials.[16]. Here, GLS is linked to cancer.